Article info
PDFBrief report
The ethics behind medical conferences: a view from India
- Correspondence to Vishal Sharma, 308 SRD Hostel, UCMS & GTB Hospital, Delhi, India; docvishalsharma{at}gmail.com
Citation
The ethics behind medical conferences: a view from India
Publication history
- Received January 16, 2010
- Revised March 18, 2010
- Accepted March 31, 2010
- First published June 16, 2010.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- Pharmaceutical industry sponsorship of academic conferences: ethics of conflict of interest
- Biomedical conflicts of interest: a defence of the sequestration thesis—learning from the cases of Nancy Olivieri and David Healy
- Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement
- “Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study
- Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies’ websites
- A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia
- Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement
- Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study
- Vaginal mesh implants: putting the relations between UK doctors and industry in plain sight
- India moves to curb unethical drug promotional practices